Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.51 +0.07 (2.87%)
Previous Close $2.44    52 Week High $4.76 
Open $2.48    52 Week Low $1.46 
Day High $2.56    P/E N/A 
Day Low $2.47    EPS $-1.91 
Volume 470,219